Skin Disorders News

Infants at high risk for atopic dermatitis who used emollients daily through their first 2 months of life experienced less disease in their first year than high-risk infants who did not use emollients, according to study results.

The use of acid suppressants among children may increase their risks for incident asthma, atopic dermatitis and allergic rhinitis, according to a systematic review published in The Journal of Allergy and Clinical Immunology: In Practice.

Remibrutinib appeared very effective in treating moderate to severe chronic spontaneous urticaria, with a rapid onset of action and a favorable safety profile, according to a study published in The Journal of Allergy & Clinical Immunology.

Subcutaneous and sublingual immunotherapy for aeroallergens improved disease severity and quality of life among patients with atopic dermatitis, according to a review published in The Journal of Allergy & Clinical Immunology.

The FDA has granted priority review to a supplemental biologics license application for the potential expanded use of lanadelumab-flyo to prevent hereditary angioedema attacks in patients aged 2 to younger than 12 years.

MILAN — In patients with seborrheic dermatitis, once-daily roflumilast foam had a significant impact on skin clearance and itch response and was tolerated well, according to phase 3 trial results.

For allergists interested in dermatology-focused findings from the European Academy of Dermatology and Venereology Congress but who could not attend the meeting this year in Milan, Healio presents this list of seven studies that may be relevant to your practice.

In patients with atopic dermatitis, ruxolitinib cream significantly reduced itch during two phase 3 trials.

Dupilumab significantly improved the signs and symptoms of moderate to severe atopic dermatitis as well as quality of life among patients aged 6 months to younger than 6 years, according to a study published in The Lancet.

MILAN — Roflumilast foam was well tolerated and efficacious in seborrheic dermatitis patients with all skin types, according to a poster presented at the European Academy of Dermatology and Venereology Congress.